Although the bisphenol derivatives 4a, 4c, 5a, and 5c showed estrogenic activity toward the MCF-7 breast cancer cell line, the corresponding alkylamino derivatives (compounds 4d and 5d) acted as ER antagonists. Here, ESR1 is linked to breast carcinoma.